Dasatinib-induced haemorrhagic colitis in chronic myeloid leukaemia (CML) in blast crisis

BMJ Case Reports

Volumn , Issue , 2013, Pages

  Chisti, Mohammad Muhsin ^a,b   Khachani, Amine ^c   Brahmanday, Govinda R ^d   Klamerus, Justin ^e  

^a OAKLAND UNIVERSITY WILLIAM BEAUMONT SCHOOL OF MEDICINE   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d Freeman Cancer Center   (United States)

^e McLaren Cancer Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DASATINIB; DEXAMETHASONE; DOXORUBICIN; HEMOGLOBIN; IMATINIB; LACTATE DEHYDROGENASE; LACTIC ACID; METHOTREXATE; NILOTINIB; STEROID; VINCRISTINE;

ABDOMINAL TENDERNESS; ABNORMAL LABORATORY RESULT; ADULT; ANEMIA; ARTICLE; BLAST CELL CRISIS; BLEEDING TENDENCY; BLOODY DIARRHEA; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; COLITIS; COLONOSCOPY; DEHYDRATION; DESCENDING COLON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FEVER; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGIC COLITIS; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INFECTIOUS COLITIS; INFLAMMATORY BOWEL DISEASE; ISCHEMIC COLITIS; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPHOCYTOSIS; MIDDLE AGED; NEUROPATHY; PANCYTOPENIA; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; RASH; RECTUM HEMORRHAGE; T LYMPHOCYTE; TACHYCARDIA; THROMBOCYTE COUNT;

EID: 84891841141     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-200610     Document Type: Article

References (13)

1. Brave M, Goodman V, Kaminskas E, et al. Sprycel for chronic myeloid leukemia and Philadelphia chromosome -positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate. Clin Cancer Res 2008;14:352-9.
2. Lombardo LJ, Lee FY, Chen P, et al. Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-[2-hydroxyethyl]-piperazin-1-yl)-2-methylpyrimidin-4-ylamino) thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem 2004;47:6658-61.
3. Shah NP, Kantarjian HM, Kim DW, et al. Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia. J Clin Oncol 2008;26:3204-12.
4. Erkut M, Erkut N, Ersoz S, et al. A case of acute colitis with severe rectal bleeding in a patient with chronic myeloid leukemia after dasatinib use. Acta Haematol 2010;123:205-6.
5. Shimokaze T, Mitsui T, Takeda H, et al. Severe hemorrhagic colitis caused by dasatinib in Philadelphia chromosome positive acute lymphoblastic leukemia. Pediatr Hematol Oncol 2009;26:448- 53.
6. Patodi N, Sagar N, Rudzki Z, et al. Haemorrhagic colitis caused by dasatinib. Case Rep Hematol 2012;2012:417106.
7. Sunami Y, Sato E, Ichikawa K, et al. Hemorrhagic colitis caused by dasatinib following cytomegalovirus enterocolitis in a patient with chronic myelogenous leukemia in the second chronic phase. Rinsho Ketsueki 2011;52:282-6.
8. Quintas-Cardama A, Kantarjian H, Ravandi F, et al. Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapy. Cancer 2009;115:2482-90.
9. Powers JJ, Dubovsky JA, Epling-Burnette PK, et al. A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors. Leuk Lymphoma 2011;52:668-79.
10. Mustjoki S, Ekblom M, Arstila TP, et al. Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia 2009;23:1398-405.
11. Lee SJ, Jung CW, Kim DY, et al. Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia. Am J Hematol 2011;86:346-50.
12. Bixby DL. Managing inadequate responses to frontline treatment of chronic myeloid leukemia: a case-based review. Cancer Treat Rev 2013:39;241-51.
13. Kmira Z, Nesrine BS, Houneida Z. Severe hemorrhagic colitis in a patient with chronic myeloid leukemia in the blastic phase after dasatinib use. World J Gastrointest Pathophysiol 2013;4:59-62.